Every year, millions of people visit their doctors seeking relief from conjunctivitis, which always involves eye redness or swelling, and can be caused by a virus, bacterium or allergens. However, it can sometimes be difficult to make a firm diagnosis because symptoms are often the same no matter the cause, driving the need for specific POC diagnostic tests. Proper differential diagnosis is an essential prerequisite for appropriate treatment.
Currently, an Allergic Conjunctivitis (AC) diagnosis is confirmed by patient history, invasive eye swab or skin test, serum test or even a negative viral test leading to inefficiencies and increased costs1. The Allereye™ Tear Total IgE Test confirms the presence of IgE antibodies in tears. It also offers the ability to now make a specific POC diagnosis, which can prevent unnecessary dry-eye treatment and unnecessary antibiotic regimen mandated by the Affordable Care Act.
Allergic Conjunctivitis is one of the most common disorders of the ocular surface, and it affects approximately 30% of the population, both in the United States and worldwide. Allereye provides clinics the opportunity to offer new testing and gain new efficiencies in patient care—all while reducing costs. Having specific IgE POC test results available immediately allows for quicker, more effective diagnosis and treatment. Further, by making the diagnosis in house, revenue is not lost as is often the case when testing is sent out. Allereye’s cost-effective, POC format also makes it an option for some private pay patients.
1Gomes PJ. Trends in prevalence and treatment of ocular allergy. Curr Opin Allergy Clin Immunol. 2014 Oct;14(5):451-6.